Full prescribing information 1 indications and usage tecfidera is indicated for the treatment of relapsing forms of multiple sclerosis ms, to include clinically isolated syndrome, relapsingremitting disease, and active secondary progressive disease, in adults. Lemtrada alemtuzumab injection, for intravenous use. Interrupt empliciti elotuzumab for grade 2 or higher and permanently discontinue for severe infusion reaction. Monitor for fever and other signs of infection and treat promptly. The proposed mechanism of action for alemtuzumab is antibodydependent lysis of leukemic cells following cell surface binding. The data from the 27 alemtuzumab recipients in this series show a wide variety of infectious complications. Left ventricular dysfunction and embryofetal toxicity see full prescribing information for complete boxed warning. See full prescribing information for complete boxed warning.
Campath alemtuzumab is a recombinant dnaderived humanized monoclonal antibody campath1h that is directed against the 2128 kd cell surface. Mabcampath alemtuzumab is indicated for the treatment of patients with previously untreated progressive. Autoimmunity, infusion reactions, stroke, and malignancies see full prescribing information for complete boxed warning. An observation period of 30 to 60 minutes is recommended after each perjeta infusion and before commencement of any subsequent infusion of trastuzumab or taxane see warnings and precautions 5. It is a humanized antibody with a ratderived antigenspecific, highly variable fab region and an fc region of human origin 4,5. Pulmonary toxicity in a clinical investigation using fludarabine phosphate injection in combination with pentostatin deoxycoformycin for the treatment of refractory chronic lymphocytic leukemia cll in adults, there was an unacceptably high incidence of fatal pulmonary. Highlights of prescribing information extended treatment in. Lemtrada alemtuzumab 10mgml injection concentrated. Dec 03, 2019 alemtuzumab was detected in the milk of lactating hucd52 transgenic mice following intravenous administration of alemtuzumab at a dose of 10 mgkg on postpartum days 812.
Pulmonary toxicity in a clinical investigation using fludarabine phosphate injection in combination with pentostatin deoxycoformycin for the treatment of refractory chronic lymphocytic leukemia cll in adults, there was an unacceptably high incidence of fatal pulmonary toxicity. Highlights of prescribing information these highlights do not include all the information needed to usegilenya safely and effectively. Jul 01, 2018 amikacin is rapidly absorbed after intramuscular administration. Alemtuzumab is a genetically engineered humanised igg1 kappa monoclonal. Thiotepa is a synthetic product with antitumor activity. Alemtuzumab was detected in the milk of lactating hucd52 transgenic mice following intravenous administration of alemtuzumab at a dose of 10 mgkg on postpartum days 812.
Jul 20, 2015 alemtuzumab is a humanized monoclonal antibody targeting cd52, a surface molecule with largely unknown function and which is predominantly expressed on b and t cells. These highlights do not include all the information needed to use mavenclad safely and effectively. Lemtrada is a cd52directed cytolytic monoclonal antibody indicated for the treatment of relapsing forms of multiple sclerosis ms, to include relapsing remitting disease and active secondary progressive disease, in adults. Consider additional monitoring in patients with medical conditions which predispose them to cardiovascular or pulmonary compromise. Fda warns about rare but serious risks of stroke and blood. Highlights of prescribing information for intravenous. Guide and package leaflet, and be informed about the risks of lemtrada. The associated longterm risks of infection remain poorl. Ask your healthcare provider if you are not sure if your vaccine is a live vaccine. Summary of product characteristics spc and package leaflet and labelling. Highlights of prescribing information these highlights do not. Tecfidera dimethyl fumarate prescribing information and. This will allow quick identification of new safety information. Relapsing forms of multiple sclerosis ms, to include clinically isolated syndrome, relapsingremitting disease, and active secondary progressive disease, in adults primary progressive ms, in adults 2 dosage and administration.
Alemtuzumab rch is a sterile, clear, colorless to slightly yellow, injection concentrate with ph 7. Includes dosages for multiple sclerosis and chronic lymphocytic leukemia. Lemtrada alemtuzumab 10mgml injection concentrated cas registry number not applicable description alemtuzumab rch is a recombinant dnaderived humanized monoclonal antibody directed against the 2128 kd cell surface glycoprotein, cd52. At this time there are no fdaapproved alternate ways of administering epoprostenol as flolan.
Alemtuzumab campath1h is a monoclonal igg1 antibody binding to the human cd52 protein. Cd52 is expressed on the surface of normal and malignant b and t lymphocytes, nk cells, monocytes, macrophages, and tissues of the male reproductive system. Dec 03, 2019 detailed alemtuzumab dosage information for adults and children. Jul 01, 2006 patients receiving alemtuzumab in clinical practice thus far are typically pretreated with multiple regimens of other chemotherapeutic agents, adding to an alreadyincreased risk for significant infection. The official hcp site for lemtrada for relapsing multiple sclerosis ms. Infusion reactions and cardiopulmonary arrest 1 indications and usage 1. Alemtuzumab is also approved as brand name campath, a medicine approved to treat a type of cancer called bcell chronic lymphocytic leukemia bcll. Refer todoxorubicin prescribing information for dosing, and dose modifications. Food and drug administration fda in november 2014, alemtuzumab is approved in over 30 countries for the therapy of relapsingremitting multiple. Full prescribing information 1 indications and usage ocrevus is indicated for the treatment of. In normal adult volunteers, average peak serum concentrations of about 12, 16 and 21 mcgml are obtained 1 hour after intramuscular administration of 250 mg 3. Full prescribing information 1 indications and usage avonex is indicated for the treatment of relapsing forms of multiple sclerosis ms, to include clinically isolated syndrome, relapsingremitting disease, and active secondary progressive disease, in adults. Dosage and administration baseline laboratory tests.
Highlights of prescribing information these highlights do not include all the information needed to use arzerra safely and effectively. Infectious complications associated with alemtuzumab use for. Mabcampath, innalemtuzumab european medicines agency. Libtayo, a programmed death receptor1 pd1 inhibitor, is the first and only fdaapproved therapy indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma cscc or locally advanced cscc who are not candidates for curative surgery or curative radiation 1. Highlights of prescribing information these highlights do. Dosage and administration campath package insert related medical guideline lemtrada package insert guideline. Cycle 1 is 3 weeks in duration, but may be extended to 4 weeks if the patient achieves a complete remission cr or complete remission with. Dose modifications for vectibix concerning dermatologic toxicity are provided see dosage and administration 2.
Campath administration can result in serious, including fatal, infusion reactions. Thus, alemtuzumab has a potential broad application across a spectrum of b and tcell malignancies. Data sources include ibm watson micromedex updated 4 may 2020, cerner multum updated 4 may 2020. Lemtrada alemtuzumab injection for intravenous use prescribing information. Perjeta pertuzumab injection, for intravenous use initial u. Highlights of prescribing information these highlights. Serum levels of alemtuzumab were similar in lactating mice and offspring on postpartum day and were associated with evidence of pharmacological activity decrease in. Package insert thiotepa for injection, usp description thiotepa for injection is an ethyleniminetype compound. For the first cycle, the recommended total dose of besponsa for all patients is 1. Restricted access do not disseminate or copy without approval. You can help by reporting any side effects you may get. Cd52 is a glycosylphosphatidylinositol gpianchored protein consisting of 12 amino acids expressed at high. Campath alemtuzumab is a recombinant dnaderived humanized monoclonal antibody campath1h that is directed against the 2128 kd cell surface glycoprotein, cd52. Amikacin is rapidly absorbed after intramuscular administration.
This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Arzerra ofatumumab injection, for intravenous use initial u. Because of its safety profile, the use of lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the. Lemtrada alemtuzumab injection, for intravenous use initial u. See the end of section 4 for how to report side effects. Alemtuzumab for the treatment of multiple sclerosis. Disclaimer the authors make no claims of the accuracy of the information contained herein.
Please see package insert for full details no medications are prohibited with the use of epoprostenol. Alemtuzumab is an emerging therapy for refractory lymphoproliferative disorders. Insert the syringe needle into the vial through the dosage in adult kidney transplant recipients nulojix should be administered in combination with basiliximab induction, mycophenolate mofetil mmf, and corticosteroids. Single doses of campath greater than 30 mg or cumulative doses greater than 90 mg per week increase the incidence of pancytopenia see package insert for warnings and precautions 5. See full prescribing information, including boxed warning.
Multiple sclerosis ms is a common inflammatory, demyelinating disease of the central nervous system cns1 with a worldwide prevalence of approximately 2. Lemtrada causes serious, sometimes fatal, autoimmune. The authors make no claims of the accuracy of the information contained herein. Taxane should be administered after perjeta and trastuzumab. Mild to moderate decreases in platelet counts, starting at the time of alemtuzumab infusion have been reported. Elotuzumab plus pomalidomide and dexamethasone for multiple myeloma. Multiple sclerosis ms only prescribers registered in the ms touch prescribing program may prescribe tysabri for multiple sclerosis see warnings and precautions 5. Fludarabine phosphate injection, usp is a sterile solution intended for intravenous administration.
1398 1441 147 487 492 365 103 903 811 116 897 225 474 855 1473 1676 262 298 26 326 624 476 10 1209 119 1039 1682 902 518 170 279 1408 26 1330 830 1036